Opportunity Often Knocks Twice- Drug diversity lends to a host of pharmaceutical opportunities: Canopus BioPharma's approach to R&D

摘要

More often than not, a compound has the potential to successfully treat a wide range of indications, usually in more than one area. This diversity can make the journey of a compound from preclinical to clinical an interesting and exciting one. Its success relies on a mixture of initiative and inquisitiveness in the discovery phase, effective preclinical studies followed by controlled and well planned clinical trials.